ARV4IDUs http://i-base.info/idu HIV treatment research for injection drug users Wed, 23 Feb 2011 23:26:51 +0000 http://backend.userland.com/rss092 en Volume 3 Number 2 – December 2010 http://i-base.info/idu/518 European Association of the Study of the Liver Monothematic Conference on Hepatitis D http://i-base.info/idu/520 US Department of Health and Human Services Guidelines for the use of antiretroviral agents in HIV-1-positive adults and adolescents publish a special section on HIV and IDUs http://i-base.info/idu/507 Needs of neglected disease going unmet: a conference overview http://i-base.info/idu/496 XVIII International AIDS Conference: 18–23 July 2010, Vienna http://i-base.info/idu/494 Navigating the IAS Vienna conference online http://i-base.info/idu/492 The Lancet series: Global HIV epidemic among people who use drugs http://i-base.info/idu/490 HTLV-II molecular epidemiology from HIV-1-positive Spanish injecting drug users http://i-base.info/idu/488 Injecting drug use and ART: monitoring survival on treatment http://i-base.info/idu/486 Dopaminergic signaling: a common neuropathogenic mechanism in the etiology of opiate addiction and neuro-AIDS http://i-base.info/idu/484 Characteristics of peripheral blood mononuclear cells of injecting drug users http://i-base.info/idu/482 High frequency of methicillin-resistant staphylococci detection at post-injecting pyo-inflammatory complications in HIV-infected injecting drug users http://i-base.info/idu/480 Poorer antiretroviral therapy outcomes in HIV-positive injecting drug users in Vietnam http://i-base.info/idu/478 Crystal methamphetamine injection predicts slower HIV RNA suppression among injection drug users http://i-base.info/idu/476 Methadone based integrated care for IDUs in Dnipropetrovsk region of Ukraine http://i-base.info/idu/474 Risk factors for depression among intravenous drug users (IDUs) receiving antiretroviral (ARV) treatment in Jakarta and Bali, Indonesia http://i-base.info/idu/472 Effective strategy to scale-up HIV services among injecting drug users (IDUs) in prisons in Bulgaria http://i-base.info/idu/469 Predictors of weight gain in a cohort of HIV-positive injection drug users (IDUs) initiating antiretroviral (ARV) therapy in Hanoi, Vietnam http://i-base.info/idu/467 Clinical and laboratory predictors of FIB-4 elevations in HCV moinofected and HCV/HIV co-infected patients http://i-base.info/idu/465 Cortisol response to stress in HIV-positive IDUs is related to depression http://i-base.info/idu/463 The impact of injection drug use cessation and antiretroviral therapy on smoking cessation among HIV-infected injection drug users in Baltimore, MD 1988-2008 http://i-base.info/idu/461 Pharmacokinetic interactions between buprenorphine/naloxone and once daily lopinavir/ritonavir http://i-base.info/idu/459 Worsening access to treatment for IDUs in the Russian Federation linked to the interruptions in ARV supply http://i-base.info/idu/457 Reference Group to the UN on HIV and Injecting Drug Use releases Consensus Statement of recommendations for global action http://i-base.info/idu/455 The International HIV/AIDS Alliance issues a good practice guide on harm reduction http://i-base.info/idu/451 Hepatitis E vaccine candidate completely blocked disease http://i-base.info/idu/449 A new report “Sinning and sinned against: the stigmatisation of problem drug users” by the UK Drug Policy Commission http://i-base.info/idu/447 Web resources http://i-base.info/idu/445 Future meetings: conference listing http://i-base.info/idu/443 Volume 3 Number 2 December 2010 http://i-base.info/idu/440 Volume 3 Number 1 – July 2010 http://i-base.info/idu/430 11th International Workshop on Clinical Pharmacology of HIV Therapy 7-9 April 2010, Sorrento, Italy http://i-base.info/idu/428 Methadone levels reduced moderately by rilpivirine (TMC278) http://i-base.info/idu/426 Raltegravir and darunavir pharmacokinetics in liver disease http://i-base.info/idu/424 17th Conference on Retrovirus and Opportunistic Infections (CROI), 16-19 February 2010, San Francisco, USA http://i-base.info/idu/422 Hepatitis studies: IL28B genetics, HCV survival, FibroScan in acute HCV, MSM reinfection and responses to transplantation http://i-base.info/idu/416 A significant transmission bottleneck among newly and recently HIV-positive IDU in St Petersburg, Russia http://i-base.info/idu/413 Similar immunologic responses to modern HAART among IDU and non-IDU in a population setting http://i-base.info/idu/409 Highly active antiretroviral therapy eliminates HIV epidemics in a network model of an Injecting Drug User community http://i-base.info/idu/406 12th European AIDS Conference (EACS) 11-14 November 2009, Cologne, Germany http://i-base.info/idu/403 Efficacy of highly active antiretroviral treatment in HIV-positive injecting drug users – results from the Danish HIV cohort study http://i-base.info/idu/401 Increasing uptake of HAART in HIV-positive ongoing drug users http://i-base.info/idu/399 Eastern Europe and Central Asia AIDS Conference (EECAAC) 28-30 October 2009, Moscow, Russian Federation http://i-base.info/idu/394 General overview of the abstracts and presentations on HIV in IDUs http://i-base.info/idu/393 49th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) 12-15 September 2009, San Francisco, USA http://i-base.info/idu/386 Efavirenz and substance use http://i-base.info/idu/383 Atazanavir and tobacco or marijuana http://i-base.info/idu/381 Darunavir/r and buprenorphine/naloxone http://i-base.info/idu/379 Raltegravir and methadone http://i-base.info/idu/377 NRTIs and buprenorphine http://i-base.info/idu/375 Changes in the marketing authorisation for PegIntron, ViraferonPeg and Rebetol http://i-base.info/idu/373 EHRN highlights the opportunity to address overdose in GFATM round 10 proposals http://i-base.info/idu/370 Lancet publishes systematic review of IDU care services http://i-base.info/idu/368 Response to the UN’s International Narcotics Control Board annual report http://i-base.info/idu/365 Web resources http://i-base.info/idu/362 Volume 3 Number 1 July 2010 http://i-base.info/idu/358 Volume 2 Number 1 October 2009 http://i-base.info/idu/117 5th IAS Conference on HIV Pathogenesis, Treatment and Prevention, 19-23 July 2009, Cape Town http://i-base.info/idu/193 Influence of HIV infection on renal function among heroin users http://i-base.info/idu/191 Risk of developing specific AIDS-defining illnesses in patients coinfected with HIV and HCV with or without liver cirrhosis http://i-base.info/idu/195 Response to first line antiretroviral therapy in patients with and without a history of IDU in Indonesia http://i-base.info/idu/188 Screening, enrolment, and follow-up of IDUs in an HIV pre-exposure prophylaxis trial in Bangkok http://i-base.info/idu/185 HIV, HCV and somatic co-morbidity in a heroin maintenance centre in Switzerland – a case for an integrative medical approach to harm-reduction http://i-base.info/idu/183 Performance of simple non-invasive scores to predict fibrosis in HIV/HCV co-infection in daily clinical practice http://i-base.info/idu/181 Liver disease is associated with HIV/HCV co-infection and alcohol use among IDUs in Chennai, India http://i-base.info/idu/179 Hunger and food insufficiency are independently correlated with unprotected sex among HIV-positive IDUs both with and without HAART http://i-base.info/idu/177 Drug and alcohol dependence: new advances and ongoing challenges in HIV treatment and prevention http://i-base.info/idu/175 International Harm Reduction Conference (Harm Reduction 2009), 20-23 April 2009, Bangkok http://i-base.info/idu/173 Reflections on the politics of harm reduction and the global response to HIV http://i-base.info/idu/171 Michel Kazatchkine discusses funding shortfall in harm reduction programmes http://i-base.info/idu/169 Taiwan harm reduction programme for IDUs praised http://i-base.info/idu/167 UNGASS Commission on Narcotic Drugs (CND), 11-13 March 2009, Vienna http://i-base.info/idu/165 Victory for maintaining the status quo http://i-base.info/idu/161 16th Conference on Retrovirus and Opportunistic Infections (CROI), 8-11 February 2009, Montreal http://i-base.info/idu/158 Waning of virological benefits following directly administered ART among drug users: results from a randomised, controlled trial http://i-base.info/idu/156 Effect of substance abuse on ART pharmacokinetics http://i-base.info/idu/154 HIV among IDU in Almaty, Kazhakstan: driving forces and implications for HIV treatment http://i-base.info/idu/152 During first 45 days post HAART initiation patients hospitalised most often for non-AIDS-defining infections: an interview with Stephen Berry, MD http://i-base.info/idu/150 German vote on use of medical heroin opens door to EU consensus on drug treatment http://i-base.info/idu/146 Iran estimates 20,000 people with HIV/AIDS: 78% related to IDU http://i-base.info/idu/144 IRIN News examines HIV/AIDS awareness levels among IDUs in Myanmar http://i-base.info/idu/142 US CDC report examines high-risk behaviors associated with HIV among IDUs http://i-base.info/idu/139 Thai activists Paisan Suwannawong and Karyn Kaplan receive international award http://i-base.info/idu/136 ARV4IDUs editorial assistant http://i-base.info/idu/134 Web resources http://i-base.info/idu/132 Abstracts from IHR conference in Bangkok http://i-base.info/idu/130 Learning from each other: enhancing community-based harm reduction programmes and practices in Canada http://i-base.info/idu/128 At what cost: HIV and human rights consequences of the global war on drugs http://i-base.info/idu/126 HIV/AIDS surveillance in injection drug users (through 2006) http://i-base.info/idu/124 Volume 2 Number 1 October 2009 PDF http://i-base.info/idu/88 Volume 1 Number 4 December 2008 http://i-base.info/idu/250 Antiretrovirals calculated to extend life expectancy by 35 years but still a 10 year difference for IDU http://i-base.info/idu/37 Key papers on methadone and ritonavir http://i-base.info/idu/42 17th International AIDS Conference, 3-8 August 2008, Mexico City http://i-base.info/idu/248 Substance use and harm reduction http://i-base.info/idu/35 Injection drug users and HIV: evidence based review of clinical treatment considerations http://i-base.info/idu/244 Staphylococcal infections among injection drug users http://i-base.info/idu/242 Abacavir and heart disease: SMART study supports an abacavir-associated increased risk of cardiovascular disease http://i-base.info/idu/239 Impact of current, former or no injecting drug use on ARV access and response in Swiss patients http://i-base.info/idu/237 Success in access to ART treatment for IDUs through PLHA network and community participation, Vietnam http://i-base.info/idu/235